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Background
The risk stratification of patients with pulmonary hyper-
tension (PHTN) using non-invasive techniques is chal-
lenging. 4D analysis techniques of right ventricular (RV)
strain may provide unique opportunities for the identifi-
cation of high-risk individuals. However, conventional
strain metrics, developed for left ventricular geometry,
pose limitations for RV geometry and its associated fibre
orientations. In this study we examine a novel 4D strain
analysis tool affording calculation of axis-independent
Principal strains for the assessment of right ventricular
mechanics. Patients with mild-moderate and severe
PHTN were studied in comparison to a young healthy
volunteer cohort.
Methods
Fifteen patients with PHTN, defined as a mean pulmon-
ary arterial pressure (PAP) >25mmHg at right heart
catheterization, and 18 young healthy volunteers were
studied. Severe PHTN was defined as a mean PAP
≥55mmHg. A standardized imaging protocol was per-
formed using a 3T MRI scanner. Cine images were
blindly analyzed for LV and RV volumes using commer-
cial software (cvi42, Circle Cardiovascular Inc., Calgary).
4D strain analysis was performed using prototype soft-
ware, generating a 3D end-diastolic mesh model of the
RV and then deforming this model within a 4D displa-
cement field, the latter contributed to by short and
long-axis cine image data (Figure 1). Peak Principal
Strain Amplitude (PPSA) and Normalized Time to Peak
(NTTP) strain were obtained for each model node and a
novel metric calculated called the “Normalized Strain
Attainment Rate” (NorStAR), where NorStAR = PPSA /
NNTP (Figure 1). The latter composite metric was
hypothesized to represent global RV electro-mechanical
recruitment.
Results
The mean age of the PHTN cohort and healthy volun-
teers was 62.5±6.4yrs and 26.6±5.8yrs respectively.
Among those with mild-moderate PHTN (n=10) the
mean PAP was 39.2±9.4 (n=10) versus 62.4±9.0mmHg
among those with severe PHTN (n=5). As shown in
Figure 2 a significant difference in NorStAR was identi-
fied between severe PHTN and healthy controls (-30±10
vs -47±9, p=0.002), while no difference was seen for
mild-moderate PHTN (-44±10 vs 47±9, P=N.S.). The
capacity of NorStAR to identify patients with invasive
hemodynamics of severe PHTN was incrementally
assessed using ROC analysis. This achieved an AUC of
0.85 for the identification of severe PHTN with a
threshold of -38 providing optimal sensitivity (80%) and
specificity (60%).
Conclusions
In this pilot study, we demonstrate the feasibility of 4D
Strain analysis using Principal Strains for the characteri-
zation of RV mechanical deformation in PHTN. A novel
marker, NorStAR, accurately identified patients with
invasive hemodynamic evidence of severe versus non-
severe PHTN and may be of value for the risk stratifica-
tion of this population.
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Figure 1 Analysis of right ventricle (RV) myocardial strain. (A) The 3D-distribution of Maximum Principal Strain (%) across the RV wall at end-
diastole and end-systole. (B) Illustration of the NorStAR calculation as the ratio between the Peak Principal Strain Amplitude (PPSA) and the
Normalized Time To Peak (NTTP; as a percentage of the cardiac cycle).
Figure 2 Mean values of the NorStAR strain parameter. NorStAR in
healthy volunteers, mild-moderate patients, and patients with
severe pulmonary hypertension, indicating a significant impairment
in the severe group (* p<0.01).
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